# A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth

> **NCT06193304** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 6 (—)

## Conditions studied

- Gaucher's Disease

## Interventions

- **DRUG:** Eliglustat

## Key facts

- **NCT ID:** NCT06193304
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-25
- **Primary completion:** 2014-09-21
- **Final completion:** 2014-09-21
- **Target enrollment:** 6 (—)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06193304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06193304, "A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06193304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*